nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—ABCG2—Lamivudine—hepatitis B	0.286	1	CbGbCtD
Leflunomide—PTK2B—blood plasma—hepatitis B	0.0177	0.226	CbGeAlD
Leflunomide—DHODH—blood—hepatitis B	0.0102	0.131	CbGeAlD
Leflunomide—Foetor hepaticus—Adefovir Dipivoxil—hepatitis B	0.00989	0.0196	CcSEcCtD
Leflunomide—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.00965	0.0191	CcSEcCtD
Leflunomide—Creatine phosphokinase increased—Telbivudine—hepatitis B	0.00898	0.0178	CcSEcCtD
Leflunomide—Liver disorder—Adefovir Dipivoxil—hepatitis B	0.00823	0.0163	CcSEcCtD
Leflunomide—PTK2B—Alpha-synuclein signaling—UBE2L3—hepatitis B	0.00815	0.0624	CbGpPWpGaD
Leflunomide—DHODH—liver—hepatitis B	0.00799	0.102	CbGeAlD
Leflunomide—Autoimmune disorder—Lamivudine—hepatitis B	0.00797	0.0158	CcSEcCtD
Leflunomide—Blood creatine phosphokinase increased—Telbivudine—hepatitis B	0.00686	0.0136	CcSEcCtD
Leflunomide—Opportunistic infection—Lamivudine—hepatitis B	0.00661	0.0131	CcSEcCtD
Leflunomide—PTK2B—blood—hepatitis B	0.00647	0.0829	CbGeAlD
Leflunomide—Fungal skin infection—Lamivudine—hepatitis B	0.00637	0.0126	CcSEcCtD
Leflunomide—Cough increased—Adefovir Dipivoxil—hepatitis B	0.00613	0.0121	CcSEcCtD
Leflunomide—Bone pain—Adefovir Dipivoxil—hepatitis B	0.00586	0.0116	CcSEcCtD
Leflunomide—Raised liver function tests—Lamivudine—hepatitis B	0.00577	0.0114	CcSEcCtD
Leflunomide—Hepatocellular injury—Adefovir Dipivoxil—hepatitis B	0.00561	0.0111	CcSEcCtD
Leflunomide—CYP1A2—blood plasma—hepatitis B	0.00542	0.0695	CbGeAlD
Leflunomide—AHR—blood—hepatitis B	0.00532	0.0682	CbGeAlD
Leflunomide—CYP2C9—blood plasma—hepatitis B	0.00515	0.066	CbGeAlD
Leflunomide—Creatine phosphokinase increased—Lamivudine—hepatitis B	0.00506	0.01	CcSEcCtD
Leflunomide—PTK2B—liver—hepatitis B	0.00506	0.0649	CbGeAlD
Leflunomide—Neck pain—Telbivudine—hepatitis B	0.00478	0.00946	CcSEcCtD
Leflunomide—Hepatic failure—Entecavir—hepatitis B	0.00464	0.00919	CcSEcCtD
Leflunomide—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.00453	0.00896	CcSEcCtD
Leflunomide—AHR—Integrated Breast Cancer Pathway—APOBEC3G—hepatitis B	0.00442	0.0338	CbGpPWpGaD
Leflunomide—Anaphylactoid reaction—Entecavir—hepatitis B	0.00431	0.00853	CcSEcCtD
Leflunomide—Respiratory tract infection—Lamivudine—hepatitis B	0.00423	0.00838	CcSEcCtD
Leflunomide—AHR—liver—hepatitis B	0.00416	0.0533	CbGeAlD
Leflunomide—AHR—Adipogenesis—MIF—hepatitis B	0.00415	0.0318	CbGpPWpGaD
Leflunomide—Sepsis—Telbivudine—hepatitis B	0.0041	0.00811	CcSEcCtD
Leflunomide—Blood creatine phosphokinase increased—Lamivudine—hepatitis B	0.00387	0.00765	CcSEcCtD
Leflunomide—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00376	0.00744	CcSEcCtD
Leflunomide—Throat sore—Lamivudine—hepatitis B	0.00369	0.0073	CcSEcCtD
Leflunomide—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.00366	0.00724	CcSEcCtD
Leflunomide—Pancreatitis—Entecavir—hepatitis B	0.00354	0.007	CcSEcCtD
Leflunomide—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00345	0.00683	CcSEcCtD
Leflunomide—Amblyopia—Lamivudine—hepatitis B	0.00345	0.00682	CcSEcCtD
Leflunomide—Migraine—Telbivudine—hepatitis B	0.00337	0.00667	CcSEcCtD
Leflunomide—Neutropenia—Entecavir—hepatitis B	0.00337	0.00667	CcSEcCtD
Leflunomide—Upper respiratory tract infection—Entecavir—hepatitis B	0.00335	0.00663	CcSEcCtD
Leflunomide—PTK2B—Alpha4 beta1 integrin signaling events—CD14—hepatitis B	0.00326	0.0249	CbGpPWpGaD
Leflunomide—Hyperglycaemia—Entecavir—hepatitis B	0.00325	0.00644	CcSEcCtD
Leflunomide—Blood disorder—Lamivudine—hepatitis B	0.00319	0.0063	CcSEcCtD
Leflunomide—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00318	0.0063	CcSEcCtD
Leflunomide—Acne—Lamivudine—hepatitis B	0.00316	0.00626	CcSEcCtD
Leflunomide—Renal failure—Entecavir—hepatitis B	0.00316	0.00625	CcSEcCtD
Leflunomide—Cramp muscle—Telbivudine—hepatitis B	0.00309	0.00611	CcSEcCtD
Leflunomide—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00308	0.0061	CcSEcCtD
Leflunomide—Haematuria—Entecavir—hepatitis B	0.00307	0.00607	CcSEcCtD
Leflunomide—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00306	0.00605	CcSEcCtD
Leflunomide—Hepatobiliary disease—Entecavir—hepatitis B	0.00304	0.00602	CcSEcCtD
Leflunomide—Gastritis—Telbivudine—hepatitis B	0.00303	0.006	CcSEcCtD
Leflunomide—Vasodilation—Lamivudine—hepatitis B	0.00303	0.00599	CcSEcCtD
Leflunomide—Vasodilation procedure—Lamivudine—hepatitis B	0.00303	0.00599	CcSEcCtD
Leflunomide—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00299	0.00592	CcSEcCtD
Leflunomide—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00297	0.00587	CcSEcCtD
Leflunomide—Influenza—Telbivudine—hepatitis B	0.00296	0.00586	CcSEcCtD
Leflunomide—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00294	0.00582	CcSEcCtD
Leflunomide—Oropharyngeal pain—Lamivudine—hepatitis B	0.00293	0.00579	CcSEcCtD
Leflunomide—Hepatitis—Entecavir—hepatitis B	0.00289	0.00571	CcSEcCtD
Leflunomide—Oedema peripheral—Entecavir—hepatitis B	0.00284	0.00563	CcSEcCtD
Leflunomide—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00282	0.00557	CcSEcCtD
Leflunomide—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.0028	0.00553	CcSEcCtD
Leflunomide—CYP1A2—Estrogen Receptor Pathway—NR0B2—hepatitis B	0.00279	0.0213	CbGpPWpGaD
Leflunomide—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00278	0.0055	CcSEcCtD
Leflunomide—Neutropenia—Telbivudine—hepatitis B	0.00277	0.00548	CcSEcCtD
Leflunomide—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00277	0.00548	CcSEcCtD
Leflunomide—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00276	0.00546	CcSEcCtD
Leflunomide—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00275	0.00545	CcSEcCtD
Leflunomide—Inflammation—Lamivudine—hepatitis B	0.00274	0.00543	CcSEcCtD
Leflunomide—Vasculitis—Lamivudine—hepatitis B	0.00273	0.00539	CcSEcCtD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—HSPA5—hepatitis B	0.00272	0.0208	CbGpPWpGaD
Leflunomide—Immune system disorder—Entecavir—hepatitis B	0.00261	0.00516	CcSEcCtD
Leflunomide—Renal failure—Telbivudine—hepatitis B	0.0026	0.00514	CcSEcCtD
Leflunomide—Neuropathy peripheral—Telbivudine—hepatitis B	0.00259	0.00512	CcSEcCtD
Leflunomide—Alopecia—Entecavir—hepatitis B	0.00255	0.00505	CcSEcCtD
Leflunomide—Mental disorder—Entecavir—hepatitis B	0.00253	0.005	CcSEcCtD
Leflunomide—Malnutrition—Entecavir—hepatitis B	0.00251	0.00497	CcSEcCtD
Leflunomide—Hepatobiliary disease—Telbivudine—hepatitis B	0.0025	0.00494	CcSEcCtD
Leflunomide—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00245	0.00485	CcSEcCtD
Leflunomide—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.00243	0.0186	CbGpPWpGaD
Leflunomide—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00242	0.00478	CcSEcCtD
Leflunomide—Mouth ulceration—Lamivudine—hepatitis B	0.00241	0.00476	CcSEcCtD
Leflunomide—Back pain—Adefovir Dipivoxil—hepatitis B	0.00237	0.00469	CcSEcCtD
Leflunomide—Hepatitis—Telbivudine—hepatitis B	0.00237	0.00469	CcSEcCtD
Leflunomide—Pharyngitis—Telbivudine—hepatitis B	0.00235	0.00466	CcSEcCtD
Leflunomide—Connective tissue disorder—Telbivudine—hepatitis B	0.00233	0.00461	CcSEcCtD
Leflunomide—Sepsis—Lamivudine—hepatitis B	0.00231	0.00457	CcSEcCtD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.00227	0.0174	CbGpPWpGaD
Leflunomide—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00227	0.00448	CcSEcCtD
Leflunomide—Lymphadenopathy—Lamivudine—hepatitis B	0.00226	0.00448	CcSEcCtD
Leflunomide—Leukopenia—Entecavir—hepatitis B	0.00225	0.00445	CcSEcCtD
Leflunomide—Sleep disorder—Lamivudine—hepatitis B	0.00223	0.00441	CcSEcCtD
Leflunomide—CYP1A2—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00221	0.017	CbGpPWpGaD
Leflunomide—Gastroenteritis—Lamivudine—hepatitis B	0.00218	0.00431	CcSEcCtD
Leflunomide—Cough—Adefovir Dipivoxil—hepatitis B	0.00214	0.00423	CcSEcCtD
Leflunomide—Mediastinal disorder—Telbivudine—hepatitis B	0.00214	0.00423	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00212	0.0042	CcSEcCtD
Leflunomide—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00209	0.00413	CcSEcCtD
Leflunomide—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00209	0.00413	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00207	0.0041	CcSEcCtD
Leflunomide—Malnutrition—Telbivudine—hepatitis B	0.00206	0.00408	CcSEcCtD
Leflunomide—ABCG2—blood—hepatitis B	0.00206	0.0264	CbGeAlD
Leflunomide—Anaphylactic shock—Entecavir—hepatitis B	0.00205	0.00406	CcSEcCtD
Leflunomide—Infection—Entecavir—hepatitis B	0.00204	0.00403	CcSEcCtD
Leflunomide—Dysgeusia—Telbivudine—hepatitis B	0.00202	0.004	CcSEcCtD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.00202	0.0155	CbGpPWpGaD
Leflunomide—Nervous system disorder—Entecavir—hepatitis B	0.00201	0.00398	CcSEcCtD
Leflunomide—ABCG2—Fluoropyrimidine Activity—CYP2A6—hepatitis B	0.002	0.0153	CbGpPWpGaD
Leflunomide—Back pain—Telbivudine—hepatitis B	0.002	0.00395	CcSEcCtD
Leflunomide—Skin disorder—Entecavir—hepatitis B	0.00199	0.00394	CcSEcCtD
Leflunomide—CYP1A2—blood—hepatitis B	0.00199	0.0255	CbGeAlD
Leflunomide—Muscle spasms—Telbivudine—hepatitis B	0.00199	0.00393	CcSEcCtD
Leflunomide—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00196	0.00388	CcSEcCtD
Leflunomide—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00196	0.00388	CcSEcCtD
Leflunomide—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00194	0.00385	CcSEcCtD
Leflunomide—Ill-defined disorder—Telbivudine—hepatitis B	0.00192	0.00379	CcSEcCtD
Leflunomide—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00191	0.00377	CcSEcCtD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.00191	0.0146	CbGpPWpGaD
Leflunomide—Migraine—Lamivudine—hepatitis B	0.0019	0.00376	CcSEcCtD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.00189	0.0145	CbGpPWpGaD
Leflunomide—CYP2C9—blood—hepatitis B	0.00189	0.0242	CbGeAlD
Leflunomide—Malaise—Telbivudine—hepatitis B	0.00186	0.00368	CcSEcCtD
Leflunomide—Insomnia—Entecavir—hepatitis B	0.00186	0.00367	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00182	0.00361	CcSEcCtD
Leflunomide—Dyspepsia—Entecavir—hepatitis B	0.00181	0.00357	CcSEcCtD
Leflunomide—Cough—Telbivudine—hepatitis B	0.0018	0.00356	CcSEcCtD
Leflunomide—Liver function test abnormal—Lamivudine—hepatitis B	0.00178	0.00353	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Entecavir—hepatitis B	0.00177	0.0035	CcSEcCtD
Leflunomide—Fatigue—Entecavir—hepatitis B	0.00177	0.0035	CcSEcCtD
Leflunomide—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00176	0.00348	CcSEcCtD
Leflunomide—Chest pain—Telbivudine—hepatitis B	0.00176	0.00348	CcSEcCtD
Leflunomide—Myalgia—Telbivudine—hepatitis B	0.00176	0.00348	CcSEcCtD
Leflunomide—Arthralgia—Telbivudine—hepatitis B	0.00176	0.00348	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00175	0.00345	CcSEcCtD
Leflunomide—Cramp muscle—Lamivudine—hepatitis B	0.00174	0.00344	CcSEcCtD
Leflunomide—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00174	0.00344	CcSEcCtD
Leflunomide—Discomfort—Telbivudine—hepatitis B	0.00174	0.00344	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00173	0.00342	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IFNAR2—hepatitis B	0.00169	0.013	CbGpPWpGaD
Leflunomide—Gastrointestinal pain—Entecavir—hepatitis B	0.00168	0.00332	CcSEcCtD
Leflunomide—Influenza—Lamivudine—hepatitis B	0.00167	0.0033	CcSEcCtD
Leflunomide—Nervous system disorder—Telbivudine—hepatitis B	0.00165	0.00327	CcSEcCtD
Leflunomide—Thrombocytopenia—Telbivudine—hepatitis B	0.00165	0.00326	CcSEcCtD
Leflunomide—Pancreatitis—Lamivudine—hepatitis B	0.00164	0.00324	CcSEcCtD
Leflunomide—Skin disorder—Telbivudine—hepatitis B	0.00164	0.00324	CcSEcCtD
Leflunomide—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00164	0.00324	CcSEcCtD
Leflunomide—Sweating increased—Lamivudine—hepatitis B	0.00163	0.00322	CcSEcCtD
Leflunomide—Body temperature increased—Entecavir—hepatitis B	0.00162	0.00321	CcSEcCtD
Leflunomide—Abdominal pain—Entecavir—hepatitis B	0.00162	0.00321	CcSEcCtD
Leflunomide—ABCG2—liver—hepatitis B	0.00161	0.0207	CbGeAlD
Leflunomide—Bronchitis—Lamivudine—hepatitis B	0.00161	0.00318	CcSEcCtD
Leflunomide—Pancytopenia—Lamivudine—hepatitis B	0.00159	0.00314	CcSEcCtD
Leflunomide—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00158	0.00313	CcSEcCtD
Leflunomide—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00158	0.00313	CcSEcCtD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.00158	0.0121	CbGpPWpGaD
Leflunomide—Dysuria—Lamivudine—hepatitis B	0.00156	0.00309	CcSEcCtD
Leflunomide—Neutropenia—Lamivudine—hepatitis B	0.00156	0.00309	CcSEcCtD
Leflunomide—CYP1A2—liver—hepatitis B	0.00155	0.0199	CbGeAlD
Leflunomide—Pollakiuria—Lamivudine—hepatitis B	0.00154	0.00305	CcSEcCtD
Leflunomide—CYP1A2—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00154	0.0118	CbGpPWpGaD
Leflunomide—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00154	0.00304	CcSEcCtD
Leflunomide—Insomnia—Telbivudine—hepatitis B	0.00152	0.00301	CcSEcCtD
Leflunomide—Paraesthesia—Telbivudine—hepatitis B	0.00151	0.00299	CcSEcCtD
Leflunomide—AHR—Adipogenesis—FAS—hepatitis B	0.00151	0.0116	CbGpPWpGaD
Leflunomide—Hyperglycaemia—Lamivudine—hepatitis B	0.00151	0.00298	CcSEcCtD
Leflunomide—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.00151	0.0115	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—ALPL—hepatitis B	0.00149	0.0114	CbGpPWpGaD
Leflunomide—Dyspepsia—Telbivudine—hepatitis B	0.00148	0.00293	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-DPA1—hepatitis B	0.00148	0.0113	CbGpPWpGaD
Leflunomide—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00148	0.00292	CcSEcCtD
Leflunomide—CYP2C9—liver—hepatitis B	0.00147	0.0189	CbGeAlD
Leflunomide—AHR—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.00147	0.0113	CbGpPWpGaD
Leflunomide—AHR—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.00147	0.0113	CbGpPWpGaD
Leflunomide—Asthenia—Entecavir—hepatitis B	0.00147	0.00291	CcSEcCtD
Leflunomide—Renal failure—Lamivudine—hepatitis B	0.00146	0.0029	CcSEcCtD
Leflunomide—Neuropathy peripheral—Lamivudine—hepatitis B	0.00146	0.00289	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00145	0.00288	CcSEcCtD
Leflunomide—Fatigue—Telbivudine—hepatitis B	0.00145	0.00287	CcSEcCtD
Leflunomide—Stomatitis—Lamivudine—hepatitis B	0.00145	0.00287	CcSEcCtD
Leflunomide—Jaundice—Lamivudine—hepatitis B	0.00145	0.00287	CcSEcCtD
Leflunomide—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00145	0.0111	CbGpPWpGaD
Leflunomide—Pain—Telbivudine—hepatitis B	0.00144	0.00285	CcSEcCtD
Leflunomide—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00144	0.00284	CcSEcCtD
Leflunomide—PTK2B—Osteopontin-mediated events—NFKB1—hepatitis B	0.00142	0.0109	CbGpPWpGaD
Leflunomide—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00142	0.0028	CcSEcCtD
Leflunomide—Hepatobiliary disease—Lamivudine—hepatitis B	0.00141	0.00279	CcSEcCtD
Leflunomide—Epistaxis—Lamivudine—hepatitis B	0.0014	0.00278	CcSEcCtD
Leflunomide—Diarrhoea—Entecavir—hepatitis B	0.0014	0.00278	CcSEcCtD
Leflunomide—Sinusitis—Lamivudine—hepatitis B	0.0014	0.00276	CcSEcCtD
Leflunomide—Agranulocytosis—Lamivudine—hepatitis B	0.00139	0.00275	CcSEcCtD
Leflunomide—Feeling abnormal—Telbivudine—hepatitis B	0.00139	0.00275	CcSEcCtD
Leflunomide—Gastrointestinal pain—Telbivudine—hepatitis B	0.00138	0.00273	CcSEcCtD
Leflunomide—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00137	0.00271	CcSEcCtD
Leflunomide—Dizziness—Entecavir—hepatitis B	0.00136	0.00268	CcSEcCtD
Leflunomide—Rhinitis—Lamivudine—hepatitis B	0.00134	0.00265	CcSEcCtD
Leflunomide—Hepatitis—Lamivudine—hepatitis B	0.00134	0.00264	CcSEcCtD
Leflunomide—Body temperature increased—Telbivudine—hepatitis B	0.00133	0.00263	CcSEcCtD
Leflunomide—Abdominal pain—Telbivudine—hepatitis B	0.00133	0.00263	CcSEcCtD
Leflunomide—PTK2B—Signaling of Hepatocyte Growth Factor Receptor—PTEN—hepatitis B	0.00133	0.0102	CbGpPWpGaD
Leflunomide—Pharyngitis—Lamivudine—hepatitis B	0.00133	0.00262	CcSEcCtD
Leflunomide—Connective tissue disorder—Lamivudine—hepatitis B	0.00131	0.0026	CcSEcCtD
Leflunomide—Vomiting—Entecavir—hepatitis B	0.0013	0.00258	CcSEcCtD
Leflunomide—Rash—Entecavir—hepatitis B	0.00129	0.00256	CcSEcCtD
Leflunomide—Dermatitis—Entecavir—hepatitis B	0.00129	0.00256	CcSEcCtD
Leflunomide—CYP1A2—Xenobiotics—CYP2A6—hepatitis B	0.00129	0.00986	CbGpPWpGaD
Leflunomide—Headache—Entecavir—hepatitis B	0.00129	0.00254	CcSEcCtD
Leflunomide—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00127	0.00252	CcSEcCtD
Leflunomide—Erythema multiforme—Lamivudine—hepatitis B	0.00126	0.0025	CcSEcCtD
Leflunomide—Rash—Adefovir Dipivoxil—hepatitis B	0.00126	0.0025	CcSEcCtD
Leflunomide—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00126	0.00249	CcSEcCtD
Leflunomide—Headache—Adefovir Dipivoxil—hepatitis B	0.00125	0.00248	CcSEcCtD
Leflunomide—CYP1A2—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00124	0.00948	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—CD8A—hepatitis B	0.00123	0.0094	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.00122	0.00935	CbGpPWpGaD
Leflunomide—Nausea—Entecavir—hepatitis B	0.00122	0.00241	CcSEcCtD
Leflunomide—Asthenia—Telbivudine—hepatitis B	0.00121	0.00239	CcSEcCtD
Leflunomide—Immune system disorder—Lamivudine—hepatitis B	0.00121	0.00239	CcSEcCtD
Leflunomide—Mediastinal disorder—Lamivudine—hepatitis B	0.0012	0.00238	CcSEcCtD
Leflunomide—Chills—Lamivudine—hepatitis B	0.0012	0.00237	CcSEcCtD
Leflunomide—PTK2B—IL-2 Signaling Pathway—IL2—hepatitis B	0.00119	0.00914	CbGpPWpGaD
Leflunomide—Pruritus—Telbivudine—hepatitis B	0.00119	0.00236	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IFNGR1—hepatitis B	0.00119	0.00913	CbGpPWpGaD
Leflunomide—Nausea—Adefovir Dipivoxil—hepatitis B	0.00119	0.00235	CcSEcCtD
Leflunomide—Alopecia—Lamivudine—hepatitis B	0.00118	0.00234	CcSEcCtD
Leflunomide—Malnutrition—Lamivudine—hepatitis B	0.00116	0.0023	CcSEcCtD
Leflunomide—Diarrhoea—Telbivudine—hepatitis B	0.00115	0.00228	CcSEcCtD
Leflunomide—Flatulence—Lamivudine—hepatitis B	0.00115	0.00227	CcSEcCtD
Leflunomide—Dysgeusia—Lamivudine—hepatitis B	0.00114	0.00225	CcSEcCtD
Leflunomide—Back pain—Lamivudine—hepatitis B	0.00113	0.00223	CcSEcCtD
Leflunomide—PTK2B—TCR Signaling Pathway—CCR5—hepatitis B	0.00112	0.0086	CbGpPWpGaD
Leflunomide—Muscle spasms—Lamivudine—hepatitis B	0.00112	0.00221	CcSEcCtD
Leflunomide—Dizziness—Telbivudine—hepatitis B	0.00111	0.0022	CcSEcCtD
Leflunomide—PTK2B—TCR Signaling Pathway—FAS—hepatitis B	0.00111	0.00852	CbGpPWpGaD
Leflunomide—PTK2B—IL2-mediated signaling events—IFNG—hepatitis B	0.0011	0.00841	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—IL2—hepatitis B	0.00109	0.00835	CbGpPWpGaD
Leflunomide—Ill-defined disorder—Lamivudine—hepatitis B	0.00108	0.00214	CcSEcCtD
Leflunomide—PTK2B—Signaling by Interleukins—IL18—hepatitis B	0.00108	0.00825	CbGpPWpGaD
Leflunomide—Anaemia—Lamivudine—hepatitis B	0.00108	0.00213	CcSEcCtD
Leflunomide—Vomiting—Telbivudine—hepatitis B	0.00107	0.00212	CcSEcCtD
Leflunomide—AHR—Circadian rythm related genes—FAS—hepatitis B	0.00107	0.00816	CbGpPWpGaD
Leflunomide—Angioedema—Lamivudine—hepatitis B	0.00106	0.0021	CcSEcCtD
Leflunomide—Rash—Telbivudine—hepatitis B	0.00106	0.0021	CcSEcCtD
Leflunomide—Dermatitis—Telbivudine—hepatitis B	0.00106	0.0021	CcSEcCtD
Leflunomide—PTK2B—CXCR4-mediated signaling events—HLA-DRB1—hepatitis B	0.00106	0.00809	CbGpPWpGaD
Leflunomide—Headache—Telbivudine—hepatitis B	0.00106	0.00209	CcSEcCtD
Leflunomide—Malaise—Lamivudine—hepatitis B	0.00105	0.00208	CcSEcCtD
Leflunomide—CYP1A2—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.00105	0.00802	CbGpPWpGaD
Leflunomide—Vertigo—Lamivudine—hepatitis B	0.00105	0.00207	CcSEcCtD
Leflunomide—Leukopenia—Lamivudine—hepatitis B	0.00104	0.00206	CcSEcCtD
Leflunomide—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00103	0.00792	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—MX1—hepatitis B	0.00102	0.00785	CbGpPWpGaD
Leflunomide—PTK2B—Coregulation of Androgen receptor activity—CDKN2A—hepatitis B	0.00102	0.00782	CbGpPWpGaD
Leflunomide—Cough—Lamivudine—hepatitis B	0.00102	0.00201	CcSEcCtD
Leflunomide—Nausea—Telbivudine—hepatitis B	0.001	0.00198	CcSEcCtD
Leflunomide—Chest pain—Lamivudine—hepatitis B	0.000991	0.00196	CcSEcCtD
Leflunomide—Myalgia—Lamivudine—hepatitis B	0.000991	0.00196	CcSEcCtD
Leflunomide—Arthralgia—Lamivudine—hepatitis B	0.000991	0.00196	CcSEcCtD
Leflunomide—Anxiety—Lamivudine—hepatitis B	0.000987	0.00195	CcSEcCtD
Leflunomide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000984	0.00195	CcSEcCtD
Leflunomide—Discomfort—Lamivudine—hepatitis B	0.000979	0.00194	CcSEcCtD
Leflunomide—PTK2B—IL2-mediated signaling events—IL2—hepatitis B	0.000976	0.00747	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—AKR1B1—hepatitis B	0.000971	0.00743	CbGpPWpGaD
Leflunomide—Dry mouth—Lamivudine—hepatitis B	0.000969	0.00192	CcSEcCtD
Leflunomide—Anaphylactic shock—Lamivudine—hepatitis B	0.00095	0.00188	CcSEcCtD
Leflunomide—Infection—Lamivudine—hepatitis B	0.000943	0.00187	CcSEcCtD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—CDKN1A—hepatitis B	0.000934	0.00715	CbGpPWpGaD
Leflunomide—Nervous system disorder—Lamivudine—hepatitis B	0.000931	0.00184	CcSEcCtD
Leflunomide—DHODH—Metabolism—GGT2—hepatitis B	0.00093	0.00713	CbGpPWpGaD
Leflunomide—Thrombocytopenia—Lamivudine—hepatitis B	0.00093	0.00184	CcSEcCtD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—hepatitis B	0.000928	0.0071	CbGpPWpGaD
Leflunomide—Skin disorder—Lamivudine—hepatitis B	0.000922	0.00182	CcSEcCtD
Leflunomide—Hyperhidrosis—Lamivudine—hepatitis B	0.000918	0.00182	CcSEcCtD
Leflunomide—AHR—Circadian rythm related genes—NOS2—hepatitis B	0.000911	0.00698	CbGpPWpGaD
Leflunomide—Anorexia—Lamivudine—hepatitis B	0.000905	0.00179	CcSEcCtD
Leflunomide—Hypotension—Lamivudine—hepatitis B	0.000887	0.00176	CcSEcCtD
Leflunomide—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000865	0.00171	CcSEcCtD
Leflunomide—Insomnia—Lamivudine—hepatitis B	0.000859	0.0017	CcSEcCtD
Leflunomide—PTK2B—Coregulation of Androgen receptor activity—CTNNB1—hepatitis B	0.000855	0.00654	CbGpPWpGaD
Leflunomide—Paraesthesia—Lamivudine—hepatitis B	0.000853	0.00169	CcSEcCtD
Leflunomide—AHR—Adipogenesis—CTNNB1—hepatitis B	0.00085	0.00651	CbGpPWpGaD
Leflunomide—Dyspnoea—Lamivudine—hepatitis B	0.000847	0.00167	CcSEcCtD
Leflunomide—Dyspepsia—Lamivudine—hepatitis B	0.000836	0.00165	CcSEcCtD
Leflunomide—AHR—Adipogenesis—CDKN1A—hepatitis B	0.00083	0.00636	CbGpPWpGaD
Leflunomide—Decreased appetite—Lamivudine—hepatitis B	0.000826	0.00163	CcSEcCtD
Leflunomide—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00082	0.00162	CcSEcCtD
Leflunomide—Fatigue—Lamivudine—hepatitis B	0.000819	0.00162	CcSEcCtD
Leflunomide—Pain—Lamivudine—hepatitis B	0.000812	0.00161	CcSEcCtD
Leflunomide—Constipation—Lamivudine—hepatitis B	0.000812	0.00161	CcSEcCtD
Leflunomide—PTK2B—LPA receptor mediated events—NFKB1—hepatitis B	0.000798	0.00611	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—NFKB1—hepatitis B	0.000788	0.00603	CbGpPWpGaD
Leflunomide—PTK2B—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—hepatitis B	0.000783	0.006	CbGpPWpGaD
Leflunomide—Feeling abnormal—Lamivudine—hepatitis B	0.000783	0.00155	CcSEcCtD
Leflunomide—Gastrointestinal pain—Lamivudine—hepatitis B	0.000777	0.00154	CcSEcCtD
Leflunomide—Urticaria—Lamivudine—hepatitis B	0.000754	0.00149	CcSEcCtD
Leflunomide—AHR—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000754	0.00577	CbGpPWpGaD
Leflunomide—Body temperature increased—Lamivudine—hepatitis B	0.000751	0.00148	CcSEcCtD
Leflunomide—Abdominal pain—Lamivudine—hepatitis B	0.000751	0.00148	CcSEcCtD
Leflunomide—PTK2B—CXCR4-mediated signaling events—CD4—hepatitis B	0.000745	0.0057	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000735	0.00563	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000731	0.0056	CbGpPWpGaD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—hepatitis B	0.000721	0.00553	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—CD4—hepatitis B	0.000705	0.0054	CbGpPWpGaD
Leflunomide—Hypersensitivity—Lamivudine—hepatitis B	0.0007	0.00138	CcSEcCtD
Leflunomide—AHR—Adipogenesis—TGFB1—hepatitis B	0.000687	0.00526	CbGpPWpGaD
Leflunomide—Asthenia—Lamivudine—hepatitis B	0.000681	0.00135	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-DPB1—hepatitis B	0.000679	0.0052	CbGpPWpGaD
Leflunomide—Pruritus—Lamivudine—hepatitis B	0.000672	0.00133	CcSEcCtD
Leflunomide—Diarrhoea—Lamivudine—hepatitis B	0.00065	0.00129	CcSEcCtD
Leflunomide—CYP1A2—Phase II conjugation—GGT2—hepatitis B	0.000649	0.00497	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IFNB1—hepatitis B	0.000648	0.00496	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—TNF—hepatitis B	0.000641	0.00491	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—IL6—hepatitis B	0.000641	0.00491	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IFNA1—hepatitis B	0.000632	0.00484	CbGpPWpGaD
Leflunomide—Dizziness—Lamivudine—hepatitis B	0.000628	0.00124	CcSEcCtD
Leflunomide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000625	0.00479	CbGpPWpGaD
Leflunomide—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000617	0.00473	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—NFKB1—hepatitis B	0.000607	0.00465	CbGpPWpGaD
Leflunomide—Vomiting—Lamivudine—hepatitis B	0.000604	0.00119	CcSEcCtD
Leflunomide—Rash—Lamivudine—hepatitis B	0.000599	0.00118	CcSEcCtD
Leflunomide—Dermatitis—Lamivudine—hepatitis B	0.000598	0.00118	CcSEcCtD
Leflunomide—Headache—Lamivudine—hepatitis B	0.000595	0.00118	CcSEcCtD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IFNA2—hepatitis B	0.000589	0.00451	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—PTEN—hepatitis B	0.000585	0.00448	CbGpPWpGaD
Leflunomide—ABCG2—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000567	0.00434	CbGpPWpGaD
Leflunomide—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000565	0.00433	CbGpPWpGaD
Leflunomide—Nausea—Lamivudine—hepatitis B	0.000564	0.00112	CcSEcCtD
Leflunomide—DHODH—Metabolism—CYP2A6—hepatitis B	0.000564	0.00432	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL2—hepatitis B	0.00056	0.00429	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNAR2—hepatitis B	0.000553	0.00423	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—CTNNB1—hepatitis B	0.000545	0.00417	CbGpPWpGaD
Leflunomide—PTK2B—Oncostatin M Signaling Pathway—TP53—hepatitis B	0.00054	0.00414	CbGpPWpGaD
Leflunomide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000535	0.00409	CbGpPWpGaD
Leflunomide—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000527	0.00404	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—NFKB1—hepatitis B	0.000525	0.00402	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—IL6—hepatitis B	0.000517	0.00396	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—CTNNB1—hepatitis B	0.000515	0.00394	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GOT2—hepatitis B	0.00051	0.0039	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000507	0.00388	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—TGFB1—hepatitis B	0.000506	0.00387	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL18—hepatitis B	0.000502	0.00385	CbGpPWpGaD
Leflunomide—AHR—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000501	0.00384	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DPA1—hepatitis B	0.000483	0.0037	CbGpPWpGaD
Leflunomide—CYP1A2—Arachidonic acid metabolism—GGT1—hepatitis B	0.000483	0.0037	CbGpPWpGaD
Leflunomide—PTK2B—Cell-Cell communication—CTNNB1—hepatitis B	0.000466	0.00357	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—UBE2L3—hepatitis B	0.000458	0.00351	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD274—hepatitis B	0.000458	0.00351	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000457	0.0035	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000445	0.0034	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-A—hepatitis B	0.000441	0.00338	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GGT1—hepatitis B	0.00044	0.00337	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GOT1—hepatitis B	0.00044	0.00337	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000433	0.00332	CbGpPWpGaD
Leflunomide—ABCG2—Fluoropyrimidine Activity—TP53—hepatitis B	0.000432	0.00331	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—CTNNB1—hepatitis B	0.00043	0.00329	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PDCD1—hepatitis B	0.000419	0.00321	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—NFKB1—hepatitis B	0.000417	0.00319	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HLA-DRB1—hepatitis B	0.000403	0.00309	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—TP53—hepatitis B	0.000399	0.00305	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—AKR1B1—hepatitis B	0.000391	0.00299	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNGR1—hepatitis B	0.000389	0.00298	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—PTEN—hepatitis B	0.000381	0.00292	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL6—hepatitis B	0.000381	0.00292	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GGT2—hepatitis B	0.00038	0.00291	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—IL6—hepatitis B	0.000365	0.0028	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MX1—hepatitis B	0.000335	0.00256	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—IL6—hepatitis B	0.000332	0.00254	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL6—hepatitis B	0.000329	0.00252	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—IL6—hepatitis B	0.000313	0.0024	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RIT2—hepatitis B	0.000312	0.00239	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—SAG—hepatitis B	0.000312	0.00239	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—GGT1—hepatitis B	0.000307	0.00235	CbGpPWpGaD
Leflunomide—CYP1A2—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000301	0.00231	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IFNG—hepatitis B	0.000294	0.00225	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000269	0.00206	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL2—hepatitis B	0.000262	0.002	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hepatitis B	0.000251	0.00192	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—NFKB1—hepatitis B	0.000245	0.00188	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HSPA5—hepatitis B	0.000235	0.0018	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—ALB—hepatitis B	0.000234	0.00179	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—CYP2A6—hepatitis B	0.00023	0.00176	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hepatitis B	0.000223	0.0017	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DPB1—hepatitis B	0.000222	0.0017	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TLR2—hepatitis B	0.000213	0.00163	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNB1—hepatitis B	0.000212	0.00162	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.00021	0.00161	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.00021	0.00161	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000208	0.0016	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNA1—hepatitis B	0.000207	0.00158	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD14—hepatitis B	0.000192	0.00147	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNA2—hepatitis B	0.000192	0.00147	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GGT1—hepatitis B	0.00018	0.00138	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PTEN—hepatitis B	0.000179	0.00137	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000178	0.00136	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hepatitis B	0.000174	0.00133	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL18—hepatitis B	0.000164	0.00126	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD40LG—hepatitis B	0.000163	0.00125	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hepatitis B	0.000162	0.00124	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000162	0.00124	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD8A—hepatitis B	0.000162	0.00124	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—AKR1B1—hepatitis B	0.000157	0.0012	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—hepatitis B	0.000154	0.00118	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000152	0.00117	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GGT2—hepatitis B	0.000151	0.00115	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-A—hepatitis B	0.000144	0.0011	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—TLR4—hepatitis B	0.000132	0.00101	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DRB1—hepatitis B	0.000132	0.00101	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CXCL10—hepatitis B	0.000123	0.000944	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IFNG—hepatitis B	9.61e-05	0.000736	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CCR5—hepatitis B	9.56e-05	0.000732	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CD4—hepatitis B	9.28e-05	0.000711	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP2A6—hepatitis B	9.12e-05	0.000698	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL2—hepatitis B	8.54e-05	0.000654	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GOT2—hepatitis B	8.25e-05	0.000632	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CTNNB1—hepatitis B	8.25e-05	0.000632	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—F2—hepatitis B	8.2e-05	0.000628	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ALB—hepatitis B	8.09e-05	0.000619	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	8.07e-05	0.000618	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—CDKN1A—hepatitis B	8.06e-05	0.000617	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PTEN—hepatitis B	8.04e-05	0.000616	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—NFKB1—hepatitis B	8e-05	0.000613	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—AKR1B1—hepatitis B	7.93e-05	0.000607	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GGT2—hepatitis B	7.6e-05	0.000582	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GGT1—hepatitis B	7.12e-05	0.000545	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GOT1—hepatitis B	7.12e-05	0.000545	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	6.9e-05	0.000528	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—AKR1B1—hepatitis B	6.78e-05	0.000519	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GGT2—hepatitis B	6.5e-05	0.000498	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL2—hepatitis B	5.52e-05	0.000423	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CTNNB1—hepatitis B	5.33e-05	0.000408	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CDKN1A—hepatitis B	5.21e-05	0.000399	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PTEN—hepatitis B	5.2e-05	0.000398	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NFKB1—hepatitis B	5.17e-05	0.000396	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—hepatitis B	5.02e-05	0.000385	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP2A6—hepatitis B	4.61e-05	0.000353	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TGFB1—hepatitis B	4.31e-05	0.00033	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.29e-05	0.000329	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GOT2—hepatitis B	4.17e-05	0.000319	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP2A6—hepatitis B	3.94e-05	0.000301	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ALB—hepatitis B	3.79e-05	0.00029	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.67e-05	0.000281	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GGT1—hepatitis B	3.6e-05	0.000275	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GOT1—hepatitis B	3.6e-05	0.000275	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GOT2—hepatitis B	3.56e-05	0.000273	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TP53—hepatitis B	3.55e-05	0.000272	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.28e-05	0.000251	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—hepatitis B	3.25e-05	0.000249	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GGT1—hepatitis B	3.07e-05	0.000235	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GOT1—hepatitis B	3.07e-05	0.000235	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PTEN—hepatitis B	2.89e-05	0.000221	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.8e-05	0.000214	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ALB—hepatitis B	1.91e-05	0.000146	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ALB—hepatitis B	1.63e-05	0.000125	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PTEN—hepatitis B	1.46e-05	0.000112	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PTEN—hepatitis B	1.25e-05	9.55e-05	CbGpPWpGaD
